Devon Atkinson

8PUBLICATIONS
68CO-AUTHORS
Molecular targetsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 02, 2026
HDAC Inhibition Unlocks Tumor Plasticity and Enhances Immunotherapy Response in Myc-Driven Small Cell Lung Cancer.

|Apr 22, 2026
Blockade of Tumor-Intrinsic TGFβ Signaling Drives Hyperprogression in Small Cell Lung Cancer.

|Jan 26, 2024
Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer.

Nitin Roper, Rajaa El Meskini, Tapan Maity

|Jul 26, 2023
ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer.

Christopher W Schultz, Yang Zhang, Rajaa Elmeskini

|Apr 20, 2022
Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models.

Delphine Lissa, Nobuyuki Takahashi, Parth Desai

|Apr 23, 2021
Distinct Biomarker Profiles and TCR Sequence Diversity Characterize the Response to PD-L1 Blockade in a Mouse Melanoma Model.

Rajaa El Meskini, Devon Atkinson, Alan Kulaga

Pageof 2

Frequent Collaborators

6 joint publications

Zoë Weaver Ohler

6 joint publications

Rajaa Elmeskini

5 joint publications

Anish Thomas

3 joint publications

Brett Schroeder